BrightPath Biotherapeutics Co., Ltd.

TSE:4594 Stock Report

Market Cap: JP¥4.6b

BrightPath Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4594?
Owner TypeNumber of SharesOwnership Percentage
Institutions-651,734-0.787%
Individual Insiders3,332,8004.03%
General Public80,110,23496.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.6%.


Top Shareholders

Top 16 shareholders own 10.13% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
1.71%
Macquarie Group, Ltd., Banking & Securities Investments
1,418,500JP¥78.0m84.6%no data
1.13%
Evolution Capital Management LLC
939,600JP¥51.7m-24.6%0.49%
0.92%
Rakuten Investment Management, Inc.
762,400JP¥41.9m0%0.02%
0.8%
Matsui Securities Co. Ltd., Asset Management Arm
660,900JP¥36.3m0%0.15%
0.72%
Hiroshi Akeo
600,000JP¥33.0m0%no data
0.56%
Kazumi Araki
467,300JP¥25.7m0%no data
0.54%
Mitsubishi UFJ Capital Co., Ltd.
450,000JP¥24.8m0%0.14%
0.51%
Takehiko Nakazato
425,000JP¥23.4m0%no data
0.5%
SBI Holdings Inc., Asset Management Arm
412,994JP¥22.7m0%0.01%
0.49%
Japan Securities Finance Co. Ltd., Asset Management Arm
408,600JP¥22.5m0%no data
0.45%
Shunsuke Nakamura
373,000JP¥20.5m0%no data
0.43%
Akira Nishimura
360,000JP¥19.8m0%no data
0.43%
Kazuhiko Kaneko
355,300JP¥19.5m0%no data
0.4%
Shinaaki Katsura
327,200JP¥18.0m0%no data
0.29%
Kenichi Nagai
240,000JP¥13.2m0%no data
0.22%
Akira Yamada
185,000JP¥10.2m0%no data